AU7854094A - Use of amiodarone for the treatment of heart failure - Google Patents
Use of amiodarone for the treatment of heart failureInfo
- Publication number
- AU7854094A AU7854094A AU78540/94A AU7854094A AU7854094A AU 7854094 A AU7854094 A AU 7854094A AU 78540/94 A AU78540/94 A AU 78540/94A AU 7854094 A AU7854094 A AU 7854094A AU 7854094 A AU7854094 A AU 7854094A
- Authority
- AU
- Australia
- Prior art keywords
- amiodarone
- treatment
- heart failure
- heart
- failure
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 206010019280 Heart failures Diseases 0.000 title 1
- IYIKLHRQXLHMJQ-UHFFFAOYSA-N amiodarone Chemical compound CCCCC=1OC2=CC=CC=C2C=1C(=O)C1=CC(I)=C(OCCN(CC)CC)C(I)=C1 IYIKLHRQXLHMJQ-UHFFFAOYSA-N 0.000 title 1
- 229960005260 amiodarone Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/556—Angiotensin converting enzyme inhibitors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Vascular Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP93116013 | 1993-10-04 | ||
| EP93116013 | 1993-10-04 | ||
| PCT/EP1994/003267 WO1995009625A1 (en) | 1993-10-04 | 1994-09-30 | Use of amiodarone for the treatment of heart failure |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU7854094A true AU7854094A (en) | 1995-05-01 |
Family
ID=8213319
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU78540/94A Abandoned AU7854094A (en) | 1993-10-04 | 1994-09-30 | Use of amiodarone for the treatment of heart failure |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU7854094A (en) |
| IL (1) | IL111144A0 (en) |
| WO (1) | WO1995009625A1 (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU4777896A (en) * | 1995-02-10 | 1996-08-27 | G.D. Searle & Co. | Use of low dose amount of spironolactone for treatment of cardiovascular disease |
| NZ305528A (en) * | 1995-02-10 | 2001-05-25 | G | Combination of angiotensin converting enzyme inhibitor and an aldosterone antagonist |
| FR2735365B1 (en) * | 1995-06-14 | 1997-09-05 | Sanofi Sa | USE OF AN ANGIOTENSIN II ANTAGONIST AND A BENZOFURANE DERIVATIVE FOR THE PREPARATION OF A MEDICAMENT USEFUL IN THE TREATMENT OF CARDIOVASCULAR CONDITIONS |
| FR2746013B1 (en) * | 1996-03-18 | 1998-05-29 | Sanofi Sa | USE OF ANTIARRHYTHMIC COMPOUNDS IN THE PREVENTION OF POST INFARCT MORTALITY |
| FR2760364A1 (en) * | 1997-03-10 | 1998-09-11 | Sanofi Sa | USE OF ANTIARRHYTHMIC COMPOUNDS FOR REDUCING MORTALITY AFTER MYOCARDIAL INFARCTION |
| US6048874A (en) * | 1999-01-26 | 2000-04-11 | Medeva Pharmaceuticals Manufacturing, Inc. | Parenteral metolazone formulations |
| CN102423305A (en) * | 2011-12-23 | 2012-04-25 | 中国药科大学 | Isosorbide mononitrate micro-porous osmotic pump tablet and preparation method thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2626176A1 (en) * | 1988-01-25 | 1989-07-28 | Baligadoo Soorianarain | Cardioprotective medicinal preparations comprising amiodarone, a nitro derivative and optionally a beta-blocker |
| US4931464A (en) * | 1989-02-15 | 1990-06-05 | E. R. Squibb & Sons, Inc. | Method of reducing pre- and post-ischemic myocardial arrhythmias and fibrillation |
| EP0413694B1 (en) * | 1989-02-20 | 1993-05-12 | BALIGADOO, Soorianarain | Cardio-protective drug preparations comprising amiodarone, a nitrate derivate, in particular isosorbide dinitrate and optionally a beta-blocker |
-
1994
- 1994-09-30 AU AU78540/94A patent/AU7854094A/en not_active Abandoned
- 1994-09-30 WO PCT/EP1994/003267 patent/WO1995009625A1/en not_active Ceased
- 1994-10-03 IL IL11114494A patent/IL111144A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO1995009625A1 (en) | 1995-04-13 |
| IL111144A0 (en) | 1994-12-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU7545594A (en) | Implantable device for the treatment of aedemas | |
| AU2484692A (en) | Cardiac arrest treatment | |
| AU665899B2 (en) | Artificial heart | |
| AU2093392A (en) | Treatment of congestive heart failure | |
| AU6316794A (en) | Medical stent | |
| AU7567394A (en) | Treatment chamber catheter | |
| AU3802493A (en) | Surgical endoclip | |
| AU1966992A (en) | Skin treatment system | |
| AU4944093A (en) | Osteosynthesis aid | |
| AU3548795A (en) | Benzopyranopyrazolyl derivatives for the treatment of inflammation | |
| AU7045594A (en) | Surgical stockinette | |
| AU6801694A (en) | The treatment of small animals | |
| AU3625295A (en) | Low profile defibrillation catheter | |
| AU1115095A (en) | Treatment of cellulose | |
| AU6253094A (en) | Methods for the treatment of osteoporosis | |
| AU2424895A (en) | Substituted spirodienes for the treatment of inflammation | |
| AU4774597A (en) | Use of 1-hydroxy-2-pyridones for the treatment of skin infections | |
| AU4705193A (en) | Medicaments for the treatment or prevention of elevated intraocular pressure | |
| AU7421391A (en) | Patient hoists | |
| AU2807492A (en) | Use of misoprostol for the treatment of allergy | |
| AU2806692A (en) | Medicament for the treatment of anxiety | |
| AU7854094A (en) | Use of amiodarone for the treatment of heart failure | |
| AU6927894A (en) | 4-amidinophenylsulphonamides for the treatment of thrombo-embolitic conditions | |
| AU1650792A (en) | Treatment of polyurethane surfaces | |
| AU5340594A (en) | Skin treatment |